Drugs

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes

By John A. Hey, Susan Abushakra, Aidan Power, Martin Tolar

Trial in peopleInterventions

medRxiv4 Oct 2026
Tool converts plasma pTau217 values across testing platforms
Research Square4 Oct 2026
Brain diffusivity modifies plasma pTau217 links to pathology
medRxiv5 Oct 2026
Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults